Abstract
Background: Colorectal cancer (CRC) is the third most common cancer worldwide. Recently, mesenchymal stem cells (MSCs) have been considered a suitable cell therapy option for cancer due to their high migration rate to the tumor site.
Objectives: The study aimed to compare the effects of human umbilical cord blood derived-MSC (UCMSC) and human Wharton’s Jelly derived-MSC (WJ-MSC) on the HT-29 cell line.
Methods: UC-MSC was obtained by Ficoll-Paque density gradient and WJ-MSC by explant method. The characterizations of MSCs and apoptosis assays were performed by flow cytometry, and caspase-3 protein levels were measured by ELISA.
Results: After 72 hours of HT-29 cancer cells incubation, it was indicated that WJ-MSC was more effective at 1:5 and 1:10 ratios. Similar results were found for caspase-3 by ELISA. Moreover, WJ-MSC (1:5, p < 0.006; 1:10, p < 0.007) was found to be more effective at both doses compared to UC-MSC.
Conclusion: In this study, we used two different MSC sources at two different ratios to evaluate the apoptotic effect of MSC in vitro on HT-29 CRC cells. As a result, WJ-MSC indicated a more apoptotic effect on HT-29 cells compared to CB-MSC. We anticipated that this preliminary in vitro study would be extended in future in vitro/in vivo studies. Moreover, investigating the behavior of MSC in colorectal tumor microenvironment will be beneficial for the stem cell therapy approach.
Keywords: Colorectal cancer, human umbilical cord blood derived-MSC, human Wharton’s Jelly derived-MSC, apoptosis, anti-cancer cell therapy, HT-29 CRC cells, tumor.
[http://dx.doi.org/10.2147/CIA.S109285] [PMID: 27486317]
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[http://dx.doi.org/10.1155/2018/7628763] [PMID: 30533404]
[PMID: 27766137]
[http://dx.doi.org/10.3389/fbioe.2020.00043] [PMID: 32117924]
[http://dx.doi.org/10.1002/cyto.a.23242] [PMID: 29072818]
[http://dx.doi.org/10.1080/14653240600855905] [PMID: 16923606]
[http://dx.doi.org/10.1007/s10561-019-09781-8] [PMID: 31338647]
[http://dx.doi.org/10.21873/anticanres.14284] [PMID: 32487597]
[http://dx.doi.org/10.1016/j.arcmed.2020.08.006] [PMID: 32977984]
[http://dx.doi.org/10.4143/crt.2004.36.5.303] [PMID: 20368820]
[http://dx.doi.org/10.1007/s10495-016-1323-5] [PMID: 27798717]
[PMID: 29801534]
[http://dx.doi.org/10.1007/978-1-4939-9167-9_8] [PMID: 30798524]
[http://dx.doi.org/10.1016/j.jcyt.2020.06.002] [PMID: 32718875]
[http://dx.doi.org/10.1038/srep18772] [PMID: 26752044]
[http://dx.doi.org/10.3791/54356] [PMID: 27500972]
[http://dx.doi.org/10.1101/pdb.prot087288] [PMID: 27803250]
[http://dx.doi.org/10.1016/j.neulet.2007.05.006] [PMID: 18055116]
[http://dx.doi.org/10.2174/1574888X10666150723145911] [PMID: 26201864]
[http://dx.doi.org/10.1128/MMBR.64.4.821-846.2000] [PMID: 11104820]
[PMID: 32774818]
[http://dx.doi.org/10.1016/j.tice.2020.101413] [PMID: 32835945]
[http://dx.doi.org/10.1186/s13287-015-0055-8] [PMID: 25889203]
[http://dx.doi.org/10.1053/j.gastro.2013.08.033] [PMID: 23973922]
[http://dx.doi.org/10.3390/cancers12082107] [PMID: 32751163]
[http://dx.doi.org/10.3390/cancers11101432] [PMID: 31557960]
[http://dx.doi.org/10.1038/s41419-019-1508-2] [PMID: 30890699]